Unidentified cachexia patients in the oncologic setting: Cachexia UFOs do exist

Area of Science:

• Oncology
• Clinical Nutrition
• Patient Outcomes

Background:

• Cachexia significantly impacts cancer patient outcomes.
• Early identification and management of cachexia are crucial for effective cancer care.
• The TiCaCONCO trial aimed to improve nutritional therapy in cachectic cancer patients.

Purpose of the Study:

• To retrospectively analyze patient charts for data on body weight, nutritional status, and interventions in cancer patients.
• To identify the prevalence of cachexia at diagnosis and the extent of nutritional interventions by oncologists and dietitians.

Main Methods:

• Retrospective chart review of 9694 patient files in a tertiary oncology setting over 8 months.
• Data collected included patient characteristics, tumor type, body weight, nutritional status, and documented interventions.
• Screening focused on patients admitted to oncology, gastroenterology, or abdominal surgery units.

Main Results:

• Cachexia was present in 42% of newly diagnosed cancer patients, but nutritional information was missing for 46% of patients.
• Only 16% of cachectic patients received physician-initiated nutritional interventions, and 9% overall had documented interventions.
• Dietitians documented nutrition and weight for 42% of patients.

Conclusions:

• Newly diagnosed cancer patients are not systematically identified for cachexia, and nutritional interventions are insufficient.
• Barriers between oncologists and dietitians hinder effective nutritional therapy and trial success.